Efficacy and Safety of Plant Stanols and Sterols in the Management of Blood Cholesterol Levels

Katan, Martijn B.; Grundy, Scott M.; Jones, Peter; Law, Malcolm; Miettinen, Tatu; Paoletti, Rodolfo
August 2003
Mayo Clinic Proceedings;Aug2003, Vol. 78 Issue 8, p965
Academic Journal
Foods with plant stanol or sterol esters lower serum cholesterol levels. We summarize the deliberations of 32 experts on the efficacy and safety of sterols and stanols. A meta-analysis of 41 trials showed that intake of 2 g/d of stanols or sterols reduced low-density lipoprotein (LDL) by 10%; higher intakes added little. Efficacy is similar for sterols and stanols, but the food form may substantially affect LDL reduction. Effects are additive with diet or drug interventions: eating foods low in saturated fat and cholesterol and high in stanols or sterols can reduce LDL by 20%; adding sterols or stanols to statin medication is more effective than doubling the statin dose. A metaanalysis of 10 to 15 trials per vitamin showed that plasma levels of vitamins A and D are not affected by stanols or sterols. Alpha carotene, lycopene, and vitamin E levels remained stable relative to their carrier molecule, LDL. Beta carotene levels declined, but adverse health outcomes were not expected. Sterol-enriched foods increased plasma sterol levels, and workshop participants discussed whether this would increase risk, in view of the marked increase of atherosclerosis in patients with homozygous phytosterolemia. This risk is believed to be largely hypothetical, and any increase due to the small increase in plasma plant sterols may be more than offset by the decrease in plasma LDL. There are insufficient data to suggest that plant stanols or sterols either prevent or promote colon carcinogenesis. Safety of sterols and stanols is being monitored by follow-up of samples from the general population; however, the power of such studies to pick up infrequent increases in common diseases, if any exist, is limited. A trial with clinical outcomes probably would not answer remaining questions about infrequent adverse effects. Trials with surrogate end points such as intima-media thickness might corroborate the expected efficacy in reducing atherosclerosis. However, present evidence is sufficient to promote use of sterols and stanols for lowering LDL cholesterol levels in persons at increased risk for coronary heart disease.


Related Articles

  • Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Berger, Alvin; Jones, Peter J. H.; Abumweis, Suhad S. // Lipids in Health & Disease;2004, Vol. 3, p5 

    Plant sterols are naturally occurring molecules that humanity has evolved with. Herein, we have critically evaluated recent literature pertaining to the myriad of factors affecting efficacy and safety of plant sterols in free and esterified forms. We conclude that properly solubilized 4-desmetyl...

  • NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe. Hegele, Robert A.; Guy, Justin; Ban, Matthew R.; Wang, Jian // Lipids in Health & Disease;2005, Vol. 4, p1 

    Background: NPC1L1 encodes a putative intestinal sterol transporter which is the likely target for ezetimibe, a new type of lipid-lowering medication. We previously reported rare non-synonymous mutations in NPC1L1 in an individual who had no plasma lipoprotein response to ezetimibe. We next...

  • Plant sterol-enriched spread enhances the cholesterol-lowering potential of a fat-reduced diet. Cleghorn, C L; Skeaff, C M; Mann, J; Chisholm, A // European Journal of Clinical Nutrition;Jan2003, Vol. 57 Issue 1, p170 

    OBJECTIVE:: To determine the effect of a plant sterol-enriched spread on plasma cholesterol concentrations when replacing butter or a standard polyunsaturated spread in a diet containing 30% of energy fat. DESIGN:: Parallel butter phase followed by double-blind, randomized, cross-over...

  • Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Jones, M L; Martoni, C J; Prakash, S // European Journal of Clinical Nutrition;Nov2012, Vol. 66 Issue 11, p1234 

    Background/Objectives:The percentage of hypercholesterolemic individuals not reaching their LDL-cholesterol (LDL-C) goal remains high and additional therapeutic strategies should be evaluated. The objective of this study was to evaluate the cholesterol-lowering efficacy and mechanism of action...

  • Acute Sterol O-Acyltransferase 2 (SOAT2) Knockdown Rapidly Mobilizes Hepatic Cholesterol for Fecal Excretion. Marshall, Stephanie M.; Gromovsky, Anthony D.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    The primary risk factor for atherosclerotic cardiovascular disease is LDL cholesterol, which can be reduced by increasing cholesterol excretion from the body. Fecal cholesterol excretion can be driven by a hepatobiliary as well as a non-biliary pathway known as transintestinal cholesterol efflux...

  • Spread the Love.  // Shape;Jun2011, Vol. 30 Issue 10, p48 

    The article cites a study from researchers at the Agricultural University of Athens, Greece that revealed individuals who ate four grams of plant sterols daily, which compounds that help the body block the absorption of cholesterol, reduced their low density lipoproteins (LDL) cholesterol levels.

  • Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART. Eugenia Negredo; Isabel Puigdomènech; Silvia Marfil; Jordi Puig; Núria Pérez-Álvarez; Lidia Ruiz; Celestino Rey-Joly; Bonaventura Clotet; Julià Blanco // Journal of Antimicrobial Chemotherapy (JAC);Feb2008, Vol. 61 Issue 2, p400 

    Background Cellular cholesterol is essential for HIV replication and may control HIV spread. HIV, in turn, appears to control cholesterol metabolism. Objectives To describe the relationships between serum lipids, cellular cholesterol and viral replication during highly active antiretroviral...

  • Isolation of NPC1-Deficient Chinese Hamster Ovary Cell Mutants by Gene Trap Mutagenesis1. Higaki, Katsumi; Ninomiya, Haruaki; Sugimoto, Yuko; Suzuki, Tatsuya; Taniguchi, Miyako; Niwa, Hitoshi; Pentchev, Peter G.; Vanier, Marie T.; Ohno, Kousaku // Journal of Biochemistry;2001, Vol. 129 Issue 6, p875 

    Chinese hamster ovary cell mutants defective in the NPC1 gene (NPC1-trap) were generated by retrovirus-mediated gene trap mutagenesis from a parental cell line JP17 expressing an ecotropic retrovirus receptor. Insertion of the gene trap vector in the NPC1 gene and the absence of the gene product...

  • ALTERNATIVES TO STATINS.  // Mayo Clinic Women's Health Source;Mar2007, Vol. 11 Issue 3, p1 

    The article presents nonprescription alternatives for lower density lipoprotein (LDL) cholesterol. Diet and exercise are important in lowering cholesterol level. Regular exercise can maintain healthy weight and boost good cholesterol levels. To keep LDL low, calorie intake should not exceed 200...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics